A new British project seeks to improve the detection of lung cancer among survivors of Hodgkin鈥檚 lymphoma.
The UK-wide screening programme has been developed in Manchester and seeks to screen 500 patients over two years, as part of the existing NHS Lung Cancer Screening Programme. Developers believe this will detect lung cancer in its early stages in about 10 to 12 patients.
The developers ran a pilot project in 2022 and have now received 拢1.3 million in funding to run a national study of screening using ten Cancer Alliances in England. It will target Hodgkin鈥檚 lymphoma survivors, aged between 45 and 74, who currently smoke or who have smoked in the past.
Study leader Dr Kim Linton, from the University of Manchester, said: 鈥淚t is crucial that Hodgkin lymphoma survivors can access screening to detect lung cancer at an early stage, when it is more treatable.
鈥淢ost Hodgkin lymphoma survivors do not meet current lung cancer screening criteria, so we hope the success of this study will support an application for routine adoption across England and Wales.
鈥淚n Manchester, we have been working on a lung cancer screening programme for Hodgkin lymphoma survivors for many years, including a pilot screening study at The Christie where we detected three lung cancers in 102 people who had showed no symptoms.
鈥淭his research helped us to design the national programme and confirmed that our proposed study meets the needs of this high-risk patient group. This work also builds on Manchester鈥檚 previous track record of successfully implementing breast cancer screening for Hodgkin lymphoma survivors within the national breast cancer screening programme.鈥�
One of those to benefit from the pilot study three years ago was Joanne Murray who was diagnosed with Hodgkin鈥檚 lymphoma in 1997 at the age of 29. The screening three years ago found that she had stage 1 lung cancer although she had no symptoms. She had an operation to remove a cancerous nodule last year and is currently free of disease.
Source: University of Manchester
Link:
Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in 萝莉少女. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.
News service provided by .